-
1
-
-
0019180607
-
Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release
-
Harker LA, Malpass TW, Branson HE, et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980;56:824-34.
-
(1980)
Blood
, vol.56
, pp. 824-834
-
-
Harker, L.A.1
Malpass, T.W.2
Branson, H.E.3
-
2
-
-
0025959559
-
Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation
-
published erratum appears in Blood 1991;78:545
-
Cramer EM, Lu H, Caen JP, et al. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation [published erratum appears in Blood 1991;78:545]. Blood 1991; 77:694-9.
-
(1991)
Blood
, vol.77
, pp. 694-699
-
-
Cramer, E.M.1
Lu, H.2
Caen, J.P.3
-
3
-
-
0028031807
-
On-site prothrombin time, activated partial thromboplastin time, and platelet count: A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery
-
Despotis GJ, Santoro SA, Spitznagel E, et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count: a comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 1994;80:338-51.
-
(1994)
Anesthesiology
, vol.80
, pp. 338-351
-
-
Despotis, G.J.1
Santoro, S.A.2
Spitznagel, E.3
-
4
-
-
0028006055
-
Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation
-
Despotis GJ, Santoro SA, Spitznagel E, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994;107:271-9.
-
(1994)
J Thorac Cardiovasc Surg
, vol.107
, pp. 271-279
-
-
Despotis, G.J.1
Santoro, S.A.2
Spitznagel, E.3
-
5
-
-
0028033598
-
Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy
-
Lu H, Du Buit C, Soria J, et al. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy. Thromb Haemost 1994;72: 438-43.
-
(1994)
Thromb Haemost
, vol.72
, pp. 438-443
-
-
Lu, H.1
Du Buit, C.2
Soria, J.3
-
6
-
-
0026793447
-
Early activation of hemostasis during cardiopulmonary bypass: Evidence for thrombin mediated hyperfibrinolysis
-
Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68:250-2.
-
(1992)
Thromb Haemost
, vol.68
, pp. 250-252
-
-
Teufelsbauer, H.1
Proidl, S.2
Havel, M.3
Vukovich, T.4
-
7
-
-
0031415922
-
Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome - The International Study of Peri-operative Transfusion (ISPOT) Investigators
-
Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome - the International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 1997;85:1258-67.
-
(1997)
Anesth Analg
, vol.85
, pp. 1258-1267
-
-
Laupacis, A.1
Fergusson, D.2
-
8
-
-
0026510317
-
High-dose aprotinin therapy: A review of the first five years' experience
-
Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vase Anesth 1992;6: 76-100.
-
(1992)
J Cardiothorac Vase Anesth
, vol.6
, pp. 76-100
-
-
Royston, D.1
-
9
-
-
0029010617
-
Aprotinin: A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery
-
Davis R, Whittington R. Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs 1995;49:954-83.
-
(1995)
Drugs
, vol.49
, pp. 954-983
-
-
Davis, R.1
Whittington, R.2
-
10
-
-
10544236908
-
Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens
-
Lemmer JH Jr, Dilling EW, Morton JR, et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens [see comments]. Ann Thorac Surg 1996;62: 1659-67.
-
(1996)
Ann Thorac Surg
, vol.62
, pp. 1659-1667
-
-
Lemmer Jr., J.H.1
Dilling, E.W.2
Morton, J.R.3
-
11
-
-
0028116691
-
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
-
Blauhut B, Harringer W, Bettelheim P, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:1083-91.
-
(1994)
J Thorac Cardiovasc Surg
, vol.108
, pp. 1083-1091
-
-
Blauhut, B.1
Harringer, W.2
Bettelheim, P.3
-
12
-
-
0027216882
-
Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery
-
Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11-8.
-
(1993)
J Thorac Cardiovasc Surg
, vol.106
, pp. 11-18
-
-
Huang, H.1
Ding, W.2
Su, Z.3
Zhang, W.4
-
13
-
-
0030791587
-
Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass
-
Shigeta O, Kojima H, Jikuya T, et al. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass. Circulation 1997;96:569-74.
-
(1997)
Circulation
, vol.96
, pp. 569-574
-
-
Shigeta, O.1
Kojima, H.2
Jikuya, T.3
-
14
-
-
0025271812
-
Aprotinin protects platelets against the initial effect of cardiopulmonary bypass
-
van Oeveren W, Harder MP, Roozendaal KJ, et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-96.
-
(1990)
J Thorac Cardiovasc Surg
, vol.99
, pp. 788-796
-
-
Van Oeveren, W.1
Harder, M.P.2
Roozendaal, K.J.3
-
15
-
-
0031030981
-
Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations
-
Dietrich W, Spath P, Ebell A, Richter JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997;113:194-201.
-
(1997)
J Thorac Cardiovasc Surg
, vol.113
, pp. 194-201
-
-
Dietrich, W.1
Spath, P.2
Ebell, A.3
Richter, J.A.4
-
16
-
-
0027991616
-
Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents
-
Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 1994;5:537-42.
-
(1994)
Blood Coagul Fibrinolysis
, vol.5
, pp. 537-542
-
-
Longstaff, C.1
-
17
-
-
0026087707
-
Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation
-
Lu H, Soria C, Li H, et al. Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation. Thromb Haemost 1991;65:67-72.
-
(1991)
Thromb Haemost
, vol.65
, pp. 67-72
-
-
Lu, H.1
Soria, C.2
Li, H.3
-
18
-
-
0029102222
-
Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid: Double-blind, randomized clinical trial
-
Karski JM, Teasdale SJ, Norman P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid: double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 1995;110:835-42.
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 835-842
-
-
Karski, J.M.1
Teasdale, S.J.2
Norman, P.3
-
19
-
-
0028940667
-
Tranexamic acid significantly reduces blood loss associated with coronary revascularization
-
Rousou JA, Engelman RM, Flack JE III, et al. Tranexamic acid significantly reduces blood loss associated with coronary revascularization [see comments]. Ann Thorac Surg 1995;59:671-5.
-
(1995)
Ann Thorac Surg
, vol.59
, pp. 671-675
-
-
Rousou, J.A.1
Engelman, R.M.2
Flack III, J.E.3
-
20
-
-
0030117128
-
Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients
-
Katsaros D, Petricevic M, Snow NJ, et al. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 1996;61: 1131-5.
-
(1996)
Ann Thorac Surg
, vol.61
, pp. 1131-1135
-
-
Katsaros, D.1
Petricevic, M.2
Snow, N.J.3
-
21
-
-
0030867076
-
Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double-blind, randomized, placebo controlled trial
-
Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo controlled trial. Anesth Analg 1997;85:963-70.
-
(1997)
Anesth Analg
, vol.85
, pp. 963-970
-
-
Brown, R.S.1
Thwaites, B.K.2
Mongan, P.D.3
-
22
-
-
0030016212
-
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: Aprotinin vs tranexamic acid vs epsilon aminocaproic acid
-
Menichetti A, Tritapepe L, Ruvolo G, et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. J Cardiovasc Surg (Torino) 1996;37:401-7.
-
(1996)
J Cardiovasc Surg (Torino)
, vol.37
, pp. 401-407
-
-
Menichetti, A.1
Tritapepe, L.2
Ruvolo, G.3
-
23
-
-
0028836409
-
Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting
-
Speekenbrink RG, Vonk AB, Wildevuur CR, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Ann Thorac Surg 1995;59:438-42.
-
(1995)
Ann Thorac Surg
, vol.59
, pp. 438-442
-
-
Speekenbrink, R.G.1
Vonk, A.B.2
Wildevuur, C.R.3
Eijsman, L.4
-
24
-
-
0026525226
-
Natural and synthetic antifibrinolytics in cardiac surgery
-
Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery [see comments]. Can J Anaesth 1992;39:353-65.
-
(1992)
Can J Anaesth
, vol.39
, pp. 353-365
-
-
Hardy, J.F.1
Desroches, J.2
-
25
-
-
0028946605
-
Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality
-
Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-7.
-
(1995)
Ann Thorac Surg
, vol.59
, pp. 664-667
-
-
Unsworth-White, M.J.1
Herriot, A.2
Valencia, O.3
-
26
-
-
0031913884
-
Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines
-
Price Stover E, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines. Anesthesiology 1998;88:327-33.
-
(1998)
Anesthesiology
, vol.88
, pp. 327-333
-
-
Price Stover, E.1
Siegel, L.C.2
Parks, R.3
-
28
-
-
0028692841
-
Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization
-
Kalangos A, Tayyareci G, Pretre R, et al. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization. Eur J Cardiothorac Surg 1994;8:651-6.
-
(1994)
Eur J Cardiothorac Surg
, vol.8
, pp. 651-656
-
-
Kalangos, A.1
Tayyareci, G.2
Pretre, R.3
-
29
-
-
0028314146
-
Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency: A multicenter, randomized, double-blind, placebo-controlled study
-
Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency: a multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 1994;107:543-51.
-
(1994)
J Thorac Cardiovasc Surg
, vol.107
, pp. 543-551
-
-
Lemmer Jr., J.H.1
Stanford, W.2
Bonney, S.L.3
-
30
-
-
0028294915
-
Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood
-
Havel M, Grabenwoger F, Schneider J, et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 1994;107:807-10.
-
(1994)
J Thorac Cardiovasc Surg
, vol.107
, pp. 807-810
-
-
Havel, M.1
Grabenwoger, F.2
Schneider, J.3
-
31
-
-
0031284642
-
The effects of ∈-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery
-
Slaughter TF, Faghih F, Greenberg CS, et al. The effects of ∈-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 1997;85:1221-6.
-
(1997)
Anesth Analg
, vol.85
, pp. 1221-1226
-
-
Slaughter, T.F.1
Faghih, F.2
Greenberg, C.S.3
-
32
-
-
0026632383
-
The role of desmopressin acetate in patients undergoing coronary artery bypass surgery: A controlled clinical trial with thromboelastographic risk stratification
-
Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery: a controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 1992;77:38-46.
-
(1992)
Anesthesiology
, vol.77
, pp. 38-46
-
-
Mongan, P.D.1
Hosking, M.P.2
-
33
-
-
0023133536
-
Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies
-
Spiess BD, Tuman KJ, McCarthy RJ, et al. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987;3:25-30.
-
(1987)
J Clin Monit
, vol.3
, pp. 25-30
-
-
Spiess, B.D.1
Tuman, K.J.2
McCarthy, R.J.3
|